Harmony Biosciences Holdings (HRMY) EBT (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted EBT of $39.7 million for Q1 2026, down 2.63% sequentially from $40.8 million in Q4 2025, and down 30.59% YoY from $57.2 million in Q1 2025.
Harmony Biosciences Holdings (HRMY) EBT (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported EBT for 8 years, with the latest figure at $39.7 million in Q1 2026.
- Quarterly EBT fell 30.59% year-over-year to $39.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $197.6 million (changed 0.19% YoY) and the FY2025 annual result came in at $215.1 million, up 12.13% from the prior year.
- EBT retreated to $39.7 million in Q1 2026 per HRMY's latest filing, from $40.8 million in the prior quarter.
- Over five years, EBT peaked at $67.5 million in Q3 2025 and troughed at $8.0 million in Q3 2022.
- A 5-year average of $42.6 million and a median of $44.1 million in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2023 and 2024: EBT jumped 550.58% in 2023, then sank 50.8% in 2024.
- Over 5 years, EBT stood at $44.1 million in 2022, then retreated by 10.01% to $39.7 million in 2023, then jumped by 41.49% to $56.2 million in 2024, then retreated by 27.42% to $40.8 million in 2025, then retreated by 2.63% to $39.7 million in 2026.
- According to Business Quant data, EBT over the past three periods registered $39.7 million, $40.8 million, and $67.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 93.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.27 Mn |
| Mar 31, 2026 | 39.69 Mn |
| Dec 31, 2025 | 40.76 Mn |
| Sep 30, 2025 | 67.49 Mn |
| Jun 30, 2025 | 49.64 Mn |
| Mar 31, 2025 | 57.18 Mn |
| Dec 31, 2024 | 56.16 Mn |
| Sep 30, 2024 | 62.17 Mn |
| Jun 30, 2024 | 21.69 Mn |
| Mar 31, 2024 | 51.79 Mn |
| Dec 31, 2023 | 39.69 Mn |
| Sep 30, 2023 | 51.83 Mn |
| Jun 30, 2023 | 44.10 Mn |
| Mar 31, 2023 | 37.78 Mn |
| Dec 31, 2022 | 44.10 Mn |
| Sep 30, 2022 | 7.97 Mn |
| Jun 30, 2022 | 29.23 Mn |
| Mar 31, 2022 | 23.39 Mn |
| Dec 31, 2021 | 24.48 Mn |
| Sep 30, 2021 | -10.52 Mn |